Natures Sunshine Products Inc financial data

Symbol
NATR on Nasdaq
Industry
Pharmaceutical Preparations
Location
2901 West Bluegrass Blvd., Suite 100, Lehi, UT
State of incorporation
UT
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 11, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 240 % +10.3%
Quick Ratio 93 % +2.06%
Return On Equity 4.81 % -51.5%
Return On Assets 3.18 % -49.4%
Operating Margin 4.42 % +4.99%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18.5M shares -1.32%
Common Stock, Shares, Outstanding 18.5M shares -2.08%
Entity Public Float 183M USD +2.58%
Common Stock, Value, Issued 115M USD -4.28%
Weighted Average Number of Shares Outstanding, Basic 18.6M shares -2.36%
Weighted Average Number of Shares Outstanding, Diluted 19.1M shares -1.94%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 454M USD +2.03%
Operating Income (Loss) 20.1M USD +7.18%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 18.4M USD -8.79%
Income Tax Expense (Benefit) 10.5M USD +178%
Net Income (Loss) Attributable to Parent 7.7M USD -49%
Earnings Per Share, Basic 0.41 USD/shares -48.1%
Earnings Per Share, Diluted 0.4 USD/shares -48.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 84.7M USD +2.83%
Accounts Receivable, after Allowance for Credit Loss, Current 9.48M USD +7.36%
Inventory, Net 59.4M USD -11.1%
Assets, Current 161M USD -3.16%
Deferred Income Tax Assets, Net 17.6M USD +17.1%
Property, Plant and Equipment, Net 39.6M USD -12%
Operating Lease, Right-of-Use Asset 12.8M USD -4.21%
Other Assets, Noncurrent 9.33M USD -4.61%
Assets 241M USD -3.57%
Accounts Payable, Current 8.91M USD +12.7%
Employee-related Liabilities, Current 11.2M USD -34.5%
Accrued Liabilities, Current 25.4M USD -23.4%
Contract with Customer, Liability, Current 2.77M USD +54.6%
Liabilities, Current 65.7M USD -14.4%
Deferred Income Tax Liabilities, Net 1.01M USD -28.1%
Operating Lease, Liability, Noncurrent 10.3M USD -0.95%
Other Liabilities, Noncurrent 1.35M USD +109%
Liabilities 79.9M USD -11.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -16.7M USD -8.63%
Retained Earnings (Accumulated Deficit) 57.4M USD +15.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 161M USD +0.91%
Liabilities and Equity 241M USD -3.57%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.19M USD -76.5%
Net Cash Provided by (Used in) Financing Activities 107K USD
Net Cash Provided by (Used in) Investing Activities -3.69M USD -58.7%
Common Stock, Shares Authorized 50M shares 0%
Common Stock, Shares, Issued 18.5M shares -2.08%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.6M USD -181%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 84.7M USD +2.83%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12K USD -52%
Deferred Tax Assets, Valuation Allowance 18.9M USD +1.78%
Operating Lease, Liability 14.2M USD -4.82%
Payments to Acquire Property, Plant, and Equipment 3.69M USD +58.7%
Lessee, Operating Lease, Liability, to be Paid 15.6M USD -5.85%
Property, Plant and Equipment, Gross 137M USD -1.68%
Operating Lease, Liability, Current 3.93M USD -13.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.1M USD +20.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.52M USD -15.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +24.1%
Deferred Income Tax Expense (Benefit) -157K USD +75.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.38M USD -15.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.48M USD +22.8%
Unrecognized Tax Benefits 300K USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.97M USD +26.1%
Depreciation, Depletion and Amortization 3.16M USD +12.7%
Deferred Tax Assets, Net of Valuation Allowance 19.8M USD +14.3%